Menn Teknologi Indonesia Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Menn Teknologi Indonesia Tbk. trades at Rp53 (market cap 76B), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Organon Pharma Indonesia Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| MENN | SCPI | |
|---|---|---|
Market Cap | 76B | 104.4B |
Trailing returns across standard periods
Latest headlines on both assets
PT Menn Teknologi Indonesia Tbk (the Company) was established in the Republic of Indonesia based on the Deed of Establishment No. 2 dated June 23 in Jakarta. The company started its commercial operations in 2015.
Read more on MENN →PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →